Coronary atherosclerotic heart disease
Conditions
Interventions
treatment group:Conventional Western Medicine Treatment+Phlegm Stasis Combined Treatment Formula
Control group:Conventional Western Medicine Treatment+Placebo
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Age = 18 years old and = 85 years old, gender not limited; 2. Meet the Western diagnostic criteria for acute myocardial infarction; 3. Complies with the phlegm blood stasis syndrome of coronary heart disease; 4. has undergone PCI surgery in the cardiology department of our hospital; 5. Voluntarily participate and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Combined cardiogenic shock; 2. Patients Iwho are intolerant to statins and with severe liver and kidney dysfunction (ALT or AST = 2 times ULN, Cr>177umol/L); 3. Patients with old myocardial infarction, or with malignant tumor, serious infectious diseases, inflammatory disease, blood system disease, acute cerebral infarction, etc; 4. Pregnant or lactating women, or women of childbearing age who plan to conceive within the past 2 months; 5. Have taken or are currently taking traditional Chinese medicine of the same type as the phlegm and stasis treatment formula in the past three months; 6. Individuals who have participated or are currently participating in other clinical trials within the previous month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hs-CRP; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory factors;cardiac marker;blood lipids; | — |
Countries
China
Contacts
Public ContactFan Min
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM
Outcome results
None listed